Comparative effectiveness and safety of aztreonam-avibactam or ceftazidime-avibactam plus aztreonam versus best available therapy for severe gram-negative infections: a systematic review, meta-analysis, and trial sequential analysis
DOI: 10.1007/s10096-026-05482-9Author: Changqin Chen et al.Published: 2026-3-20

Forum › Forums › Available Download: › DOI › Comparative effectiveness and safety of aztreonam-avibactam or ceftazidime-avibactam plus aztreonam versus best available therapy for severe gram-negative infections: a systematic review, meta-analysis, and trial sequential analysis

DOI: 10.1007/s10096-026-05482-9Author: Changqin Chen et al.Published: 2026-3-20

Tagged: 

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • April 12, 2026 at 11:13 pm #978
    chipdebuggerChipDebugger
    Participant

    Title: Comparative effectiveness and safety of aztreonam-avibactam or ceftazidime-avibactam plus aztreonam versus best available therapy for severe gram-negative infections: a systematic review, meta-analysis, and trial sequential analysis
    Journal: European Journal of Clinical Microbiology & Infectious Diseases
    Authors: Changqin Chen, Wenchao Mao, Changyun Zhao, Difan Lu, Weihang Hu, Jianqiang Xiong
    Date: 2026-3-20
    DOI: 10.1007/s10096-026-05482-9
    Source: Springer Science and Business Media LLC
    Source URL: https://doi.org/10.1007/s10096-026-05482-9

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.